aTyr Pharma (ATYR) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChartTranscripts

aTyr Pharma Revenue Highlights


Latest Revenue (Y)

$353.00K

Latest Revenue (Q)

$235.00K

aTyr Pharma Revenue by Period


aTyr Pharma Revenue by Year

DateRevenueChange
2023-12-31$353.00K-96.60%
2022-12-31$10.39M100.00%
2021-12-31--100.00%
2020-12-31$10.46M2377.49%
2019-12-31$422.00K100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31--

aTyr Pharma generated $353.00K in revenue during NA 2023, up -96.60% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

aTyr Pharma Revenue by Quarter

DateRevenueChange
2024-03-31$235.00K100.00%
2023-12-31--100.00%
2023-09-30$353.00K100.00%
2023-06-30-100.00%
2023-03-31--100.00%
2022-12-31$10.39M100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30--

aTyr Pharma generated $235.00K in revenue during Q1 2024, up 100.00% compared to the previous quarter, and up 2.26% compared to the same period a year ago.

ATYR Revenue FAQ


What is aTyr Pharma’s yearly revenue?

aTyr Pharma's yearly revenue for 2023 was $353K, representing a decrease of -96.60% compared to 2022. The company's yearly revenue for 2022 was $10.39M, representing an increase of 100.00% compared to 2021. ATYR's yearly revenue for 2021 was $0, representing a decrease of -100.00% compared to 2020.

What is aTyr Pharma’s quarterly revenue?

aTyr Pharma's quarterly revenue for Q1 2024 was $235K, a 100.00% increase from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $0, a -100.00% decrease from the previous quarter (Q3 2023), and a -100.00% decrease year-over-year (Q4 2022). ATYR's quarterly revenue for Q3 2023 was $353K, a 100.00% increase from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022).

What is aTyr Pharma’s revenue growth rate?

aTyr Pharma's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was -16.35%.